Loading clinical trials...
Loading clinical trials...
This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients wit...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Virginia Commonwealth University
NCT07539441 · Central Nervous System Tumors, Glioma
NCT04065776 · Glioma, Pilocytic Astrocytoma, and more
NCT03206060 · Pheochromocytoma, Paraganglioma, and more
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT05636618 · Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic, and more
Virginia Commonwealth University
Richmond, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions